project id: TCGA-ESCA; case submitter id: TCGA-JY-A938; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.4; age at index: 75; days to birth: -27633; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 27633; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1060.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Yes; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 618; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-JY-A938-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;